MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines.

Autor: Ohnstad, Hege O.1, Paulsen, Erik B.1, Noordhuis, Paul1, Berg, Marianne2,3, Lothe, Ragnhild A.2,3, Vassilev, Lyubomir T.4, Myklebost, Ola1,5 ola.myklebost@imbv.uio.no
Zdroj: BMC Cancer. 2011, Vol. 11 Issue 1, p211-221. 11p.
Databáze: Academic Search Ultimate